0001209191-18-012986.txt : 20180223 0001209191-18-012986.hdr.sgml : 20180223 20180223163225 ACCESSION NUMBER: 0001209191-18-012986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180222 FILED AS OF DATE: 20180223 DATE AS OF CHANGE: 20180223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leneghan Kathleen P. CENTRAL INDEX KEY: 0001722868 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 18636995 MAIL ADDRESS: STREET 1: ONE INVACARE WAY CITY: ELYRIA STATE: OH ZIP: 44035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 MAIL ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-22 0 0000742112 INVACARE CORP IVC 0001722868 Leneghan Kathleen P. ONE INVACARE WAY ELYRIA OH 44035 0 1 0 0 Senior VP and CFO Common Shares 2018-02-22 4 A 0 7500 0.00 A 33752 D Common Shares 4942.858 I By Invacare Retirement Savings Plan Employee Stock Option (Right to Buy) Common Shares 52400 52400 D Phantom Stock Common Shares 357.249 357.249 D Restricted shares granted pursuant to the Invacare Corporation 2013 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These shares vest in full on May 15, 2021 after a three-year "cliff" vesting period. Owned by the Trustee for the Invacare Retirement Savings Plan. The information given is based on a Plan Statement of December 31, 2017, the most recent information reasonably available. No transaction is being reported on this line. Reported on a previously filed Form 3 or Form 5. The reporting person holds previously reported options to buy 52,400 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 20, 2008 and March 18, 2013, at exercise prices between $13.37 to $25.79 per share, will expire between August 20, 2018 and March 18, 2023, and became exercisable between September 30, 2009 and March 31, 2017. Upon cessation of employment in accordance with the terms and conditions of the Invacare Corporation Deferred Compensation Plus Plan. Owned by Trustee for the Invacare Corporation Deferred Compensation Plus Plan. The information given is based on a Plan Statement of December 31, 2017, the most recent information reasonably available. /s/ Kathleen P. Leneghan, by Kristofer K. Spreen, her attorney-in-fact, pursuant to Power of Attorney dated November 10, 2017, on file with the Commission 2018-02-23